Withdrawal from chronic nicotine in adolescent and adult rats

Pharmacology Biochemistry and Behavior

Volumn 85, Issue 3, 2006, Pages 648-657

  Wilmouth, Carrie E ^a   Spear, Linda P ^a  

^a BINGHAMTON UNIVERSITY   (United States)

Author keywords

Adolescence; Anxiety; Elevated plus maze; Mecamylamine; Nicotine; Prepulsive inhibition; Startle response; Withdrawal

Indexed keywords

COTININE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE;

ADOLESCENT; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; COGNITION; CONTROLLED STUDY; EXPOSURE; MALE; MAZE TEST; NONHUMAN; ONTOGENY; OSMOTIC MINIPUMP; PERINATAL PERIOD; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; STARTLE REFLEX; TOBACCO DEPENDENCE; WEIGHT GAIN; WITHDRAWAL SYNDROME;

AGE FACTORS; ANIMALS; ANXIETY; BODY WEIGHT; MALE; MAZE LEARNING; MECAMYLAMINE; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

ANIMALIA; RATTUS;

EID: 33846206100     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.10.021     Document Type: Article

References (73)

1. Acri J.B., Grunberg N.E., and Morse D.E. Effects of nicotine on the acoustic startle reflex amplitude in rats. Psychopharmacology 104 (1991) 244-248
2. Acri J.B., Brown K.J., Saah M.I., and Grunberg N.E. Strain and age differences in acoustic startle response and effects of nicotine in rats. Pharmacol Biochem Behav 50 (1995) 191-198
3. Bell R.L., Rodd Z.A., Hsu C.C., Lumeng L., Murphy J.M., and McBride W.J. Amphetamine-modified acoustic startle responding and prepulse inhibition in adult and adolescent alcohol-preferring and -nonpreferring rats. Pharmacol Biochem Behav 75 (2003) 163-171
4. Bhattacharya S.K., Chakrabarti A., Sandler M., and Glover V. Rat brain monoamine oxidase A and B inhibitory (tribulin) activity during withdrawal anxiety. Neurosci Lett 199 (1995) 103-106
5. Breslau N., and Peterson E.L. Smoking cessation in young adults: age at initiation of cigarette smoking and other suspected influences. Am J Public Health 86 (1996) 214-220
6. Carboni E., Bortone L., Giua C., and Di Chiara G. Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats. Drug Alcohol Depend 58 (2000) 93-102
7. Carobrez A.P., and Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29 (2005) 1193-1205
8. Cheeta S., Irvine E.E., Kenny P.J., and File S.E. The dorsal raphe nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses. Psychopharmacology 155 (2001) 78-85
9. Chen J., and Millar W.J. Age of smoking initiation: implications for quitting. Health Rep 9 (1998) 39-46
10. Corrigall W.A., Zack M., Eissenberg T., Belsito L., and Scher R. Acute subjective and physiological responses to smoking in adolescents. Addiction 96 (2001) 1409-1417
11. Cruz A.P., Frei F., and Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus maze. Pharmacol Biochem Behav 49 (1994) 171-176
12. Della Casa V., Hofer I., Weiner I., and Feldon J. The effects of smoking on acoustic prepulse inhibition in healthy men and women. Psychopharmacology 137 (1998) 362-368
13. DiFranza J.R., Rigotti N.A., McNeill A.D., Ockene J.K., Savageau J.A., St. Cyr D., et al. Initial symptoms of nicotine dependence in adolescents. Tob Control 9 (2000) 313-319
14. Doremus T.L., Brunell S.C., Varlinskaya E.I., and Spear L.P. Anxiogenic effects during withdrawal from acute ethanol in adolescent and adult rats. Pharmacol Biochem Behav 75 (2003) 411-418
15. Doremus T.L., Varlinskaya E.I., and Spear L.P. Age-related differences in elevated plus maze behavior between adolescent and adult rats. Ann N Y Acad Sci 1021 (2004) 427-430
16. Erenmemisoglu A., and Tekol Y. Do nicotine metabolites have an effect on pain perception? Antinociceptive effect of cotinine in mice. Die Pharmazie 49 (1994) 374-375
17. Espejo E.F. Selective dopamine depletion within the medial prefrontal cortex induces anxiogenic-like effects in rats placed on the elevated plus maze. Brain Res 762 (1997) 281-284
18. Fagerstrom K.O., Schneider N.G., and Lunell E. Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments of tobacco withdrawal symptoms. Psychopharmacology 111 (1993) 271-277
19. Faraday M.M., O'Donoghue V.A., and Grunberg N.E. Effects of nicotine and stress on startle amplitude and sensory gating depend on rat strain and sex. Pharmacol Biochem Behav 62 (1999) 273-284
20. Faraday M.M., Elliott B.M., and Grunberg N.E. Adult vs. adolescent rats differ in biobehavioral responses to chronic nicotine administration. Pharmacol Biochem Behav 70 (2001) 475-489
21. Hatsukami D., Pentel P.R., Jensen J., Nelson D., Allen S.S., Goldman A., et al. Cotinine: effects with and without nicotine. Psychopharmacology 135 (1998) 141-150
22. Helton D.R., Modlin D.L., Tizzano J.P., and Rasmussen K. Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity. Psychopharmacology 113 (1993) 205-210
23. Hildebrand B.E., Panagis G., Svensson T.H., and Nomikos G.G. Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area. Neuropsychopharmacology 21 (1999) 560-574
24. Hughes J.R., and Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43 (1984) 289-294
25. Irvine E.E., Cheeta S., and File S.E. Development of tolerance to nicotine's anxiogenic effect in the social interaction test. Brain Res 894 (2001) 95-100
26. Johnston L.D., O'Malley P.M., Bachman J.G., and Schulenberg J.E. Monitoring the future national results on adolescent drug use: overview of key findings, 2005 (NIH Publication No. 06-5882) (2006), National Institute on Drug Abuse, Bethesda, MD
27. Keenan R.M., Hatsukami D.K., Pental P.R., Thompson T.N., and Grillo M.A. Pharmacodynamic effects of cotinine in abstinent cigarette smokers. Clin Pharmacol Ther 55 (1994) 581-590
28. Killen J.D., Ammerman S., Rojas N., Varady J., Haydel F., and Robinson T.N. Do adolescent smokers experience withdrawal effects when deprived of nicotine?. Exp Clin Psychopharmacol 9 (2001) 176-182
29. Koch M., and Schnitzler H.U. The acoustic startle response in rats-circuits mediating evocation, inhibition and potentiation. Behav Brain Res 89 (1997) 35-49
30. Koob G.F., Heinrichs S.C., Pich E.M., Menzaghi F., Baldwin H., Miczek K., et al. The role of corticotropin-releasing factor in behavioral responses to stress. Ciba Found Symp 172 (1993) 277-289
31. Kozlowski L., and Herman C. The interaction of psychosocial and biological determinants of tobacco use: more on the boundary model. J Appl Soc Psychol 14 (1984) 244-256
32. Lal H., Prather P.L., and Rezazadeh S.M. Anxiogenic behavior in rats during acute and protracted ethanol withdrawal: reversal by buspirone. Alcohol 8 (1991) 467-471
33. Lewis M.C., and Gould T.J. Nicotine and ethanol enhancements of acoustic startle reflex are mediated in part by dopamine in C57BL/6J mice. Pharmacol Biochem Behav 76 (2003) 179-186
34. Linseman M.A. Naloxone-precipitated withdrawal as a function of the morphine-naloxone interval. Psychopharmacology 54 (1977) 159-164
35. Malin D.H., Lake J.R., Newlin-Maultsby P., Roberts L.K., Lanier J.G., Carter V.A., et al. A rodent model of nicotine abstinence syndrome. Pharmacol Biochem Behav 43 (1992) 779-784
36. Malin D.H., Lake J.R., Carter V.A., Cunningham J.S., and Wilson O.B. The nicotine antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat. Psychopharmacology (Berlin) 115 (1994) 180-184
37. Martinez Z.A., Halim N.D., Oostwegel J.L., Geyer M.A., and Swerdlow N.R. Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats. Pharmacol Biochem Behav 65 (2000) 449-457
38. McNeill A.D., West R.J., Jarvis M., Jackson P., and Bryant A. Cigarette withdrawal symptoms in adolescent smokers. Psychopharmacology 90 (1986) 533-536
39. Mucha R.F., Kalant H., and Linseman M.A. Quantitative relationships among measures of morphine tolerance and physical dependence in the rat. Pharmacol Biochem Behav 10 (1979) 397-405
40. National Institutes of Health. Guide for the care and use of laboratory animals. (DHEW Publication No. 86-23) (1986), U.S. Government Printing Office, Washington, DC
41. Newman M.B., Nazian S.J., Sanberg P.R., Diamond D.M., and Shytle R.D. Corticasterone-attenuating and anxiolytic properties of mecamylamine in the rat. Prog Neuro-psychopharmacol Biol Psychiatry 25 (2001) 609-620
42. Newman M.B., Manresa J.J., Sanberg P.R., and Shytle R.D. Anxiolytic effects of mecamylamine in two animal models of anxiety. Exp Clin Psychopharmacol 10 (2002) 18-25
43. O'Dell L.E., Bruijnzeel A.W., Ghozland S., Markou A., and Koob G.F. Nicotine withdrawal in adolescent and adult rats. Ann N Y Acad Sci 1021 (2004) 167-174
44. O'Loughlin J., DiFranza J., Tyndale R., Meshefedjian G., McMillan-Davey E., Clarke P., et al. Nicotine-dependence symptoms are associated with smoking frequency in adolescents. Am J Prev Med 25 (2003) 219-225
45. Pandey S.C., Roy A., Xu T., and Mittal N. Effects of protracted nicotine exposure and withdrawal on the expression and phosphorylation of the CREB gene transcription factor in rat brain. J Neurochem 77 (2001) 943-952
46. Patterson T.R., Stringham J.D., and Meikle A.W. Nicotine and cotinine inhibit steroidogenesis in mouse leydig cells. Life Sci 46 (1990) 265-272
47. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
48. Rada P., Jensen K., and Hoebel B.G. Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens. Psychopharmacology 157 (2001) 105-110
49. Rasmussen K., Czachura J.F., Kallman M.J., and Helton D.R. The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle. NeuroReport 7 (1996) 1050-1052
50. 1A- antagonist attenuate the effects of nicotine withdrawal on the auditory startle response. Synapse 27 (1997) 145-152
51. Rodgers R.J., and Dalvi A. Anxiety, defense and the elevated plus-maze. Neurosci Biobehav Rev 21 (1997) 801-810
52. Rodgers R.J., Cole J.C., and Harrison-Phillips D.J. "Cohort removal" induces hyperthermia but fails to influence plus-maze behaviour in male mice. Physiol Behav 55 (1994) 189-192
53. Rose J.E., Herskovic J.E., Trilling Y., and Jarvik M.E. Transdermal nicotine reduces cigarette craving and nicotine preference. Clin Pharmacol Ther 384 (1985) 450-456
54. Ruiz F., Fournie-Zaluski M.C., Roques B.P., and Maldonado R. Similar decrease in spontaneous morphine abstinence by methadone and RB 101, an inhibitor of enkephalin catabolism. Br J Pharmacol 119 (1996) 174-182
55. Segal D.S., and Mandell A.J. Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 2 (1974) 249-255
56. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24 (2000) 417-463
57. Suzuki T., Ise Y., Tsuda M., Maeda J., and Misawa M. Mecamylamine-precipitated nicotine-withdrawal aversion in rats. Eur J Pharmacol 314 (1996) 281-284
58. Swerdlow N.R. Cortico-striatal substrates of cognitive, motor and sensory gating speculations and implications for psychological function and dysfunction. In: Panksepp J. (Ed). Advances in biological psychiatry vol. 2 (1996), JAI Press, Greenwich, CT 179-208
59. Swerdlow N.R., Geyer M.A., and Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 156 (2001) 194-215
60. Taioli E., and Wynder E.L. Effects of the age at which smoking begins on frequency of smoking in adulthood. N Engl J Med 325 (1991) 968-969
61. Trauth J.A., Seidler F.J., McCook E.C., and Slotkin T.A. Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Res 851 (1999) 9-19
62. Trauth J.A., McCook E.C., Seidler F.J., and Slotkin T.A. Modeling adolescent nicotine exposure: effects on cholinergic systems in rat brain regions. Brain Res 873 (2000) 18-25
63. Trauth J.A., Seidler F.J., and Slotkin T.A. An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions. Brain Res 867 (2000) 29-39
64. Trauth J.A., Seidler F.J., Ali S.F., and Slotkin T.A. Adolescent nicotine exposure produces immediate and long-term changes in CNS noradrenergic and dopaminergic function. Brain Res 892 (2001) 269-280
65. Varlinskaya E.I., and Spear L.P. Acute ethanol withdrawal (hangover) and social behavior in adolescent and adult male and female Sprague Dawley rats. Alcohol Clin Exp Res 28 (2004) 40-50
66. Vastola B.J., Douglas L.A., Varlinskaya E.I., and Spear L.P. Nicotine-induced conditioned place preference in adolescent and adult rats. Physiol Behav 77 (2002) 107-114
67. Watkins S.S., Epping-Jordan M.P., Koob G.F., and Markou A. Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol Biochem Behav 62 (1999) 743-751
68. Watkins S.S., Koob G.F., and Markou A. Neural mechanism underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob Res 2 (2000) 19-37
69. Watkins S.S., Stinus L., Koob G.F., and Markou A. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J Pharmacol Exp Ther 292 (2000) 1053-1064
70. Won Y.K., Liu J., Olivier K., Zheng Q., and Pope C.N. Age-related effects of chlorpyrifos on acetylcholine release in rat brain. Neurotoxicology 22 (2001) 39-48
71. Xu Z., Seidler F.J., Ali S.F., Slikker W., and Slotkin T.A. Fetal and adolescent nicotine administration: effects on CNS serotonergic systems. Brain Res 914 (2001) 166-178
72. Yeh J., Barbieri R.L., and Friedman A.J. Nicotine and cotinine inhibit rat testis androgen biosynthesis in vitro. J Steroid Biochem 33 (1989) 627-630
73. Zhang X., Liu C., Miao H., Gong Z.H., and Nordberg A. Postnatal changes of nicotinic acetylcholine receptor α2, α3, α4, α7, and β2 subunits genes expression in rat brain. Int J Dev Neurosci 16 (1998) 507-518